Cargando…

10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A

[Image: see text] The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurological alterations found in individuals with Down syndrome. For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacological tools. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falke, Hannes, Chaikuad, Apirat, Becker, Anja, Loaëc, Nadège, Lozach, Olivier, Abu Jhaisha, Samira, Becker, Walter, Jones, Peter G., Preu, Lutz, Baumann, Knut, Knapp, Stefan, Meijer, Laurent, Kunick, Conrad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2015
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506206/ https://www.ncbi.nlm.nih.gov/pubmed/25730262 http://dx.doi.org/10.1021/jm501994d

Ejemplares similares

[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors
por: Lechner, Christian, et al.
Publicado: (2019)

Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design
por: Meine, Rosanna, et al.
Publicado: (2018)

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
por: Walter, Anne, et al.
Publicado: (2018)

How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine
por: Wurzlbauer, Anne, et al.
Publicado: (2020)

Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives
por: Brito, Hugo, et al.
Publicado: (2015)

Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy
por: Filak, Lukas K., et al.
Publicado: (2010)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain
por: Abu Jhaisha, Samira, et al.
Publicado: (2017)

Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part I
por: Foucourt, Alicia, et al.
Publicado: (2014)

7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-ones Designed by a “Cut and Glue” Strategy Are Dual Aurora A/VEGF-R Kinase Inhibitors
por: Karatas, Mehmet, et al.
Publicado: (2021)

KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines
por: Lavrado, João, et al.
Publicado: (2015)

Dimethyl 6-iodo-2-methyl-1,2-dihydroquinoline-2,4-dicarboxylate
por: Gültekin, Zeynep, et al.
Publicado: (2013)

An efficient synthesis of indolo[2,3-b]quinoline guanidine derivatives with their in vitro and in vivo study
por: Sidoryk, Katarzyna, et al.
Publicado: (2017)

Ruthenium− and Osmium−Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity
por: Filak, Lukas K., et al.
Publicado: (2010)

3-[4-(10H-Indolo[3,2-b]quinolin-11-yl)piperazin-1-yl]propan-1-ol
por: Nichol, Gary S., et al.
Publicado: (2011)

Entropy‐Induced Selectivity Switch in Gold Catalysis: Fast Access to Indolo[1,2‐a]quinolines
por: Heckershoff, Robin, et al.
Publicado: (2022)

Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1
por: Ni, Xiaomin, et al.
Publicado: (2020)

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases
por: Myrianthopoulos, Vassilios, et al.
Publicado: (2012)

Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
por: Nguyen, Thu Lan, et al.
Publicado: (2018)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Dicopper(II) and Dizinc(II) Complexes with Nonsymmetric Dinucleating Ligands Based on Indolo[3,2-c]quinolines: Synthesis, Structure, Cytotoxicity, and Intracellular Distribution
por: Primik, Michael F., et al.
Publicado: (2013)

Defined PEG smears as an alternative approach to enhance the search for crystallization conditions and crystal-quality improvement in reduced screens
por: Chaikuad, Apirat, et al.
Publicado: (2015)

In Vitro and In Vivo Antitumor Activity of Indolo[2,3-b] Quinolines, Natural Product Analogs from Neocryptolepine Alkaloid
por: Altwaijry, Najla, et al.
Publicado: (2021)

Ruthenium- and osmium-arene complexes of 8-substituted indolo[3,2-c]quinolines: Synthesis, X-ray diffraction structures, spectroscopic properties, and antiproliferative activity
por: Filak, Lukas K., et al.
Publicado: (2012)

Transition-metal-free [3 + 3] annulation of indol-2-ylmethyl carbanions to nitroarenes. A novel synthesis of indolo[3,2-b]quinolines (quindolines)
por: Nowacki, Michał, et al.
Publicado: (2018)

Comparative structural analyses of the NHL domains from the human E3 ligase TRIM–NHL family
por: Chaikuad, Apirat, et al.
Publicado: (2022)

Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases
por: Loaëc, Nadège, et al.
Publicado: (2017)

Structural insights into a regulatory mechanism of FIR RRM1–FUSE interaction
por: Ni, Xiaomin, et al.
Publicado: (2023)

Natural Aristolactams and Aporphine Alkaloids as Inhibitors of CDK1/Cyclin B and DYRK1A
por: Marti, Guillaume, et al.
Publicado: (2013)

Guanidinium quinoline-2-carboxylate
por: Smith, Graham, et al.
Publicado: (2009)

Quinolinium 8-hydroxy-7-iodoquinoline-5-sulfonate 0.8-hydrate
por: Smith, Graham
Publicado: (2012)

Metal–Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation
por: Filak, Lukas K., et al.
Publicado: (2013)

Highly Antiproliferative Latonduine and Indolo[2,3-c]quinoline Derivatives: Complex Formation with Copper(II) Markedly Changes the Kinase Inhibitory Profile
por: Wittmann, Christopher, et al.
Publicado: (2022)

PhI(OAc)(2)-mediated intramolecular oxidative C–N coupling and detosylative aromatization: an access to indolo[2,3-b]quinolines
por: Wang, Quan-Bing, et al.
Publicado: (2021)

2-Chloroquinoline-3-carboxylic acid
por: Ladraa, Souheila, et al.
Publicado: (2010)

(Quinoline-2-carboxylato-κO)(quinoline-2-carboxylic acid-κO)bis(quinoline-2-carboxylic acid-κ(2) N,O)potassium
por: Ng, Seik Weng
Publicado: (2010)

A novel inhibitor rescues cerebellar defects in a zebrafish model of Down syndrome–associated kinase Dyrk1A overexpression
por: Buchberger, Astrid, et al.
Publicado: (2021)

Indolo[2,3-e]benzazocines and indolo[2,3-f]benzazonines and their copper(ii) complexes as microtubule destabilizing agents
por: Wittmann, Christopher, et al.
Publicado: (2023)

Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays
por: Schröder, Martin, et al.
Publicado: (2021)

5,11-Dimethyl-6,12-dimethoxyindolo[3,2-b]carbazole
por: Wrobel, Norma, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_52nv91f72hnndfsctasdtn3ebg